David L. Kaplan
Stern Family Endowed Professor of Engineering, Professor & Chair -- Dept of Biomedical Engineering, Tufts University
Lewis J. Obi
Medical Director, Cell Surgical Network of Florida; Medical Director of Obi Plastic Surgery Clinic
Professor, Department of Medicine, Brigham and Women’s Hospital; Wyss Institute for Biologically Inspired Engineering, Harvard University
Professor and Director, Collaborative Research Center for Bio/Nano Hybrid Process, Institute of Industrial Science, The University of Tokyo
Professor of Plastic Surgery and Otolaryngology, Weill Cornell Medical College
Director, MIT Synthetic Biology Center; Professor, Massachusetts Institute of Technology (MIT)
Founding Director of the Center for Engineering in Medicine, Massachusetts General Hospital and Harvard Medical School
Professor, University of Missouri-Columbia; Scientific Founder, Organovo; CSO, Modern Meadow
Professor and Head, Center for Translational Bone, Joint and Soft Tissue Research, Faculty of Medicine, Technische Universität Dresden
Professor, Harvard University
OverviewWelcome to the Second Annual Tissue Engineering, Biofabrication and 3D-Bioprinting Conference.
The fields of Tissue Engineering and 3D-Bioprinting are important for ultimately realizing the full potential of regenerative medicine. The potential to "3D-print" tissues and organs is gaining extensive interest and this conference brings together the academic as well as industry stakeholders in these expanding fields.
From a technology/methodology perspective, this conference addresses Tissue Engineering as well as Biofabrication and Bioprinting as we explore the latest developments in this field. Indeed, the field of Synthetic Biology currently with many ramifications and application areas is an important component of the broader Biofabrication space and therefore an entire conference track is devoted to this expanding field.
The focus of this conference track is to bring forth the advances in the research and industrialization of tissue engineering and 3D-bioprinting fields.
There will be a session focusing on the Clinical Translation of Tissue Engineering as means to Provide a Current State of the Landscape and Trajectory for the Future.
Posters from delegates are welcomed as a means to disseminate the most up-to-date research and commercial applications which complement the presentations from the leaders in these fields.
A co-located exhibition brings forth the technologies and commercial products in the Tissue Engineering, 3D-Bioprinting and Biofabrication fields and features companies large and small showcasing innovation.
- Biofabrication and 3D-Bioprinting Technologies and Tools
- Biomanufacturing and Biomaterials
- Clinical Translation of Tissue Engineering
- Medical and Non-Medical Applications of Bioprinted Products
- ntellectual Property and Patent Landscape in the 3D-Bioprinting Field
- Organ Printing
- Synthetic Biology and Biofabrication Technologies
- Tissue Engineering and 3D-Bioprinting Application Areas in Various Disease Classes
- Cardiovascular Disease
- Orthopaedic Applications
- Skin, Dermatology, Wound Healing
- Tissue Engineering: Disease Areas Impacted, Technologies, and Products Both Commercialized and In Development
- Companies in the Space
- Current Technology Landscape
- Developmental Pipeline of Products
Sponsorship and Exhibition Opportunities
Jeff Fan, Exhibition Manager
Confirmed Speakers to date
Matthew Applegate, Research Fellow, Ultrafast Nonlinear Optics and Biophotonics Laboratory, Tufts University
Joseph Bonventre, Samuel A. Levine Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School
Frederik Claeyssens, Senior Lecturer, Materials Science and Engineering, University of Sheffield
Eric Darling, Associate Professor of Medical Science, Engineering, and Orthopaedics, Brown University
Rong Fan, Associate Professor of Biomedical Engineering; Director, Single-Cell Profiling Core, Yale University
Adam Feinberg, Associate Professor, Carnegie Mellon University
Vera Guduric, Researcher, University of Bordeaux, France
Anwarul Hasan, Assistant Professor , Mechanical and Industrial Engineering, Qatar University
Joyce Wong, Professor, Boston University
Weibo Zhang, Research Associate, Department of Orthodontics, Tufts university, School of Dental Medicine
The speakers at this conference track represent the cutting-edge of innovation in the rapidly-expanding fields of Tissue Engineering and 3D-Bioprinting. A significant source of innovation in these fields is the construction of biological structures that can be deployed for regenerative medicine and tissue replacement.
All conference delegates receive electronic copies of the most up-to-date publications, reviews and presentations focusing on the tissue engineering and bioprinting fields. This excellent resource is invaluable for R&D presentations, business plans, investor presentations and complements the technical content presented at this conference.
This conference presents key opinion leaders (KOLs), established academic researchers, as well as young investigators -- podium presentations are derived from a broad section of these fields highlighting the most up-to-date science and innovation.
Additionally, companies in the space and industry participants who are seeking to develop and commercialize tissue engineering and 3D-bioprinting are a key feature of the content presented in this conference.